Results 41 to 50 of about 21,273,309 (234)

Caracterização molecular do HTLV-1 em pacientes com paraparesia espástica tropical/mielopatia associada ao HTLV-1 em Belém, Pará Molecular characterization of HTLV-1 among patients with tropical spastic paraparesis/HTLV-1 associated myelopathy in Belém, Pará

Revista da Sociedade Brasileira de Medicina Tropical, 2006
O presente estudo avaliou a ocorrência da infecção pelo HTLV-1 e seus subtipos em amostras de sangue de pacientes com diagnóstico clínico de paraparesia espástica tropical/mielopatia associada ao Htlv-1.
Lucinda A. Souza, Ivina G.L. Lopes, Eduardo Leitão Maia, Vânia N. Azevedo, Luiz Fernando A. Machado, Marluísa O.G. Ishak, Ricardo Ishak, Antonio Carlos R. Vallinoto   +7 more
doaj   +1 more source

Development of a Monoclonal Antibody Targeting HTLV-1 Envelope gp46 Glycoprotein and Its Application to Near-Infrared Photoimmuno-Antimicrobial Strategy

Viruses, 2022
Human T-cell leukemia virus type 1 (HTLV-1), a retrovirus, causes adult T-cell leukemia-lymphoma, HTLV-1 associated myelopathy/tropical spastic paraparesis, and HTLV-1 uveitis.
Yasuyoshi Hatayama, Yutaro Yamaoka, Takeshi Morita, Sundararaj Stanleyraj Jeremiah, Kei Miyakawa, Mayuko Nishi, Yayoi Kimura, Makoto Mitsunaga, Tadayuki Iwase, Hirokazu Kimura, Naoki Yamamoto, Akifumi Takaori-Kondo, Hideki Hasegawa, Akihide Ryo   +13 more
doaj   +1 more source

Updates on HTLV-1 Uveitis

Viruses, 2022
HTLV-1 uveitis (HU) is the third clinical entity to be designated as an HTLV-1-associated disease. Although HU is considered to be the second-most frequent HTLV-1-associated disease in Japan, information on HU is limited compared to that on adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy (HAM).
Koju Kamoi, Toshiki Watanabe, Kaoru Uchimaru, Akihiko Okayama, Seiko Kato, Toyotaka Kawamata, Hisako Kurozumi-Karube, Noe Horiguchi, Yuan Zong, Yoshihisa Yamano, Isao Hamaguchi, Yasuhito Nannya, Arinobu Tojo, Kyoko Ohno-Matsui   +13 more
openaire   +3 more sources

HTLV-1c proviral loads for 91 (asymptomatic, 75; symptomatic, 16) female and 128 (asymptomatic, 109; symptomatic, 19) male participants.

, 2021
Pearson correlation coefficients and p-values for PVL versus age are shown for symptomatic and asymptomatic subjects (symptomatic group, solid lines; asymptomatic group, dashed lines).
Antoine Gessain (31917), Mohammad Radwanur Talukder (11812779), Richard Woodman (3905950), Lloyd Einsiedel (463667), Kim Wilson (90622), John Kaldor (613150), Kerry Taylor (11812782), Hai Pham (265646)   +7 more
core   +1 more source

Clinical characteristics and outcomes of infection with human T-lymphotropic virus in a non-endemic area: a single institution study

Frontiers in Microbiology, 2023
IntroductionUnderstanding of human T-lymphotropic virus (HTLV) remains largely based on epidemiologic and clinical data from endemic areas. Globalization has resulted in migration of persons living with HTLV (PLHTLV) from endemic to non-endemic areas ...
Margery Gang, Feng Gao, Sneha Poondru, Theodore Thomas, Lee Ratner   +4 more
doaj   +1 more source

Cellular factors involved in HTLV-1 entry and pathogenicity

Frontiers in Microbiology, 2012
Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of adult T cell leukemia (ATL) and HTLV-1–associated myelopathy and tropical spastic paraparesis (HAM/TSP).
Hiroo eHoshino
doaj   +1 more source

Human T-cell leukemia virus type 1 infection among Japanese immigrants and their descendants living in Southeast Brazil: A call for preventive and control responses.

PLoS Neglected Tropical Diseases, 2021
Human T-cell leukemia virus type 1 (HTLV-1) has worldwide distribution and is considered endemic in southwestern Japan. HTLV-1 infection has been associated with adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic ...
Larissa M Bandeira, Marco A M Puga, Sabrina M S Weis-Torres, Grazielli R Rezende, João A Domingos, Tayana S O Tanaka, Gabriela A Cesar, Youko Nukui, Ana C P Vicente, Jorge Casseb, Juliana Yamashiro, Aluísio C Segurado, Murilo O Saito, João R R Pinho, Rivaldo V Cunha, Osnei Okumoto, Silvia N O Uehara, Ana R C Motta-Castro   +17 more
doaj   +1 more source

HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation Study

Viruses, 2023
The study aims to assess the usefulness of human T-cell leukemia virus type 1 (HTLV-1)-infected cell analysis using flow cytometry (HAS-Flow) as a monitoring method for adult T-cell leukemia (ATL) development in HTLV-1-positive patients with rheumatoid ...
Kunihiko Umekita, Yuki Hashikura, Akira Takaki, Masatoshi Kimura, Katsumi Kawano, Chihiro Iwao, Shunichi Miyauchi, Takeshi Kawaguchi, Motohiro Matsuda, Yayoi Hashiba, Toshihiko Hidaka   +10 more
doaj   +1 more source

HTLV-1 and Innate Immunity [PDF]

Viruses, 2011
Innate immunity plays a critical role in the host response to a viral infection. The innate response has two main functions. First, it triggers effector mechanisms that restrict the infection. Second, it primes development of the adaptive response, which completes the elimination of the pathogen or of infected cells.
Chloé Journo, Renaud Mahieux
openaire   +3 more sources

About HTLV 1

Revista de la Facultad de Ciencias de la Salud, 2013
The first description of this disease was made at Universidad del Valle by Wladimir Zaninovic, who received patients referred from the port of Tumaco in Nariño.
Tomás Zamora-Bastidas
doaj   +2 more sources